This thread has aged a little, but I just discovered this forum and would like to discuss this particular topic...
Dr. Yasko’s NutriSwitch RNA supplements are... interesting. Unapologetically $85/bottle, with not much immediate explanation as to why, or what they are, or how they differ from the $13 bottle I can get at LEF.
It was difficult to locate answers to this. This is the story I’ve managed to pull out of the web. I’m hoping Rich (or anyone else with this kind of knowledge?) can correct the errors I’m sure are contained below.
From what I can tell, she explains that NutriSwitch costs this much because she (or her colleagues) isolates particular RNA for particular functions, and concentrates them into the bottle -- and this process isn't cheap. You can buy “RNA” from other sources, but they’re generalized – i.e., represent genes expressed throughout the body.
However, from what I can tell, true encoded RNA degrades at room temperature; to keep a strand intact, you need to mostly keep it under -20C. They don't require users of NutriSwitch to do this. Dr. Yasko (and her colleague Dr. Gordon) acknowledge it will degrade, but say that doesn’t matter. They suggest this is because it’s the “nucleotide molecule” that matters, not the RNA strand.
I’m not an expert in biochemistry... but it seems to me that the genetic information is in the strand, not the molecule? If “a nucleotide” is an A, G, C, or T, then wouldn’t allowing the RNA to degrade into a soup of individual A/G/C/T causes the “speciality” of the RNA to get lost? How then can you have specialties of “stress”, “kidney”, “liver”, etc. ? Maybe the nucleotides are still useful to the body, but only in re-encoding my own genes (polymorphed or otherwise).
Maybe Dr. Yasko’s patent is relevant:
http://appft1.uspto.gov/netacgi/nph...34".PGNR.&OS=DN/20030207834&RS=DN/20030207834 I see things in here that seem to suggest specific ways in which they can “render the nucleic acid molecules substantially resistant to endogenous nuclease activity” (where “nuclease” is what otherwise degrades RNA). In contrast to the comments she and Dr. Gordon have made, the patent seems to suggest that the key is in a new way to prevent degradation, not that degradation doesn’t matter? Which is it?
Rich, have you studied this patent before? Given your expertise, does it help you understand what she’s doing? Patents don’t prove much, but it reveals something about their thinking, and you could do a much betterjob evaluating it than I could.